Computations for group sequential boundaries using the Lan-DeMets spending function method.

We describe an interactive Fortran program which performs computations related to the design and analysis of group sequential clinical trials using Lan-DeMets spending functions. Many clinical trials include interim analyses of accumulating data and rely on group sequential methods to avoid consequent inflation of the type I error rate. The computations are appropriate for interim test statistics whose distribution or limiting distribution is multivariate normal with independent increments. Recent theoretical results indicate that virtually any design likely to be used in a clinical trial will fall into this category. Interim analyses need not be equally spaced, and their number need not be specified in advance. In addition to determining sequential boundaries using an alpha spending function, the program can perform power computations, compute probabilities associated with a given set of boundaries, and generate confidence intervals.

[1]  David M. Reboussin,et al.  Information and information fractions for design and sequential monitoring of clinical trials , 1994 .

[2]  D. Schoenfeld,et al.  Sample-size formula for the proportional-hazards regression model. , 1983, Biometrics.

[3]  D L Demets,et al.  Group sequential procedures: calendar versus information time. , 1989, Statistics in medicine.

[4]  R. Bain,et al.  Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II). , 1999, Controlled clinical trials.

[5]  B. Turnbull,et al.  Group Sequential Methods with Applications to Clinical Trials , 1999 .

[6]  D L DeMets,et al.  Interim analysis: the alpha spending function approach. , 1994, Statistics in medicine.

[7]  K. K. Lan,et al.  Discrete sequential boundaries for clinical trials , 1983 .

[8]  P. O'Brien,et al.  A multiple testing procedure for clinical trials. , 1979, Biometrics.

[9]  P. Armitage,et al.  Repeated Significance Tests on Accumulating Data When the Null Hypothesis is Not True , 1971 .

[10]  J. Whitehead,et al.  A FORTRAN program for the design and analysis of sequential clinical trials. , 1983, Computers and biomedical research, an international journal.

[11]  D. Zucker,et al.  Sequential monitoring of clinical trials: the role of information and Brownian motion. , 1993, Statistics in medicine.

[12]  J. S. D. Cani,et al.  Group sequential designs using a family of type I error probability spending functions. , 1990, Statistics in medicine.

[13]  David L. DeMets,et al.  Design and analysis of group sequential tests based on the type I error spending rate function , 1987 .

[14]  K Kim,et al.  Sample size determination for group sequential clinical trials with immediate response. , 1992, Statistics in medicine.

[15]  K Kim,et al.  Design and analysis of group sequential logrank tests in maximum duration versus information trials. , 1995, Biometrics.

[16]  S. Pocock.  Group sequential methods in the design and analysis of clinical trials , 1977 .

[17]  P. Lachenbruch,et al.  The Design and Analysis of Sequential Clinical Trials (2nd ed.). , 1993 .

[18]  Y Pawitan,et al.  Statistical interim monitoring of the Cardiac Arrhythmia Suppression Trial. , 1990, Statistics in medicine.

[19]  P. Armitage,et al.  Repeated Significance Tests on Accumulating Data , 1969 .

[20]  Christopher Jennison,et al.  Group Sequential Analysis Incorporating Covariate Information , 1997 .

[21]  K Kim,et al.  Confidence intervals following group sequential tests in clinical trials. , 1987, Biometrics.

[22]  M C Wu,et al.  Sequential monitoring for comparison of changes in a response variable in clinical studies. , 1992, Biometrics.

[23]  James M. Robins,et al.  Semiparametric Efficiency and its Implication on the Design and Analysis of Group-Sequential Studies , 1997 .

[24]  J M Lachin,et al.  Implementation of group sequential logrank tests in a maximum duration trial. , 1990, Biometrics.